1-Month Bravecto (for puppies)

BRAVECTO 1-MONTH Chews for Dogs and Puppies kill adult fleas, prevent flea infestations, and treat and control ticks (black-legged tick, American dog tick, and brown dog tick) for one month in dogs and puppies 8 weeks of age and older.

Once puppies reach 6 months of age, you can easily transition them from BRAVECTO 1-MONTH Chews to the 3m extended-duration version.  This multiple-month protection will keep them safer for longer, all with a single dose.

HOW TO ADMINISTER

A single dose of BRAVECTO 1-MONTH Chews should be given to dogs and puppies by mouth with food.

IMPORTANT SAFETY INFORMATION

BRAVECTO 1-MONTH Chews are for dogs 8 weeks of age and older. Side effects may include itching, diarrhea, vomiting, decreased appetite, elevated ALT, lethargy, and weight loss. Fluralaner is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. Seizures have been reported in dogs receiving isoxazoline class drugs, even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. BRAVECTO 1-MONTH Chews are not effective against A. americanum in puppies less than 6 months of age. BRAVECTO Chews for Dogs: The most commonly reported adverse reactions include vomiting, decreased appetite, diarrhea, lethargy, polydipsia, and flatulence. BRAVECTO Chews have not been shown to be effective for 12-weeks' duration in puppies less than 6 months of age. BRAVECTO Chews are not effective against lone star ticks beyond 8 weeks of dosing. Fluralaner is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. Seizures have been reported in dogs receiving isoxazoline class drugs, even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders.